November 9, 2016 — A pioneering way to access the heart for transcatheter valve replacement has a 98 percent success ...
November 09, 2016
A discussion with Michael Reardon, M.D. about the state of transcatheter aortic valve replacement (TAVR) as of late 2016 ...
November 09, 2016
November 9, 2016 — A dedicated stent study conducted exclusively in women and minority patients evaluated clinical ...
November 09, 2016
November 9, 2016 – Results from a randomized, multicenter trial failed to show non-inferiority of hybrid, ultra-thin ...
November 09, 2016
Juan Granada, M.D., executive director and chief scientific officer of the Cardiovascular Research Foundation's Skirball ...
November 09, 2016
Brijeshwar Maini, M.D., and Brian Bethea, M.D., from Tenet Florida’s structural heart program, explain the importance of ...
November 09, 2016
Krishna Rocha-Singh, M.D., Prairie Vascular Institute, Springfield, Ill., explains advancements in device therapy for ...
November 08, 2016
David Kandzari, M.D., director of interventional cardiology and chief scientific officer, Piedmont Heart Institute ...
November 08, 2016
Studies have shown transcatheter aortic valve replacement (TAVR) has an increased risk of stroke and cerebral damage due ...
November 08, 2016
November 7, 2016 — Edwards Lifesciences Corp. recently announced new data demonstrating dramatic and sustained ...
November 07, 2016
November 7, 2016 – Results from the U.S. real-world, post-FDA approval experience of the Watchman device found high ...
November 07, 2016
November 7, 2016 — Keystone Heart Ltd. announced that data presented at the Transcatheter Cardiovascular Therapeutics ...
November 07, 2016
November 7, 2016 – Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OCT) ...
November 07, 2016
November 7, 2016 – A multicenter randomized trial evaluating the role of embolic protection using the Sentinel device ...
November 07, 2016
Polymer-Free Drug-Coated Stents More Effective Than Bare-metal Stents in High Bleeding Risk Patients
November 7, 2016 – The two-year results from LEADERS FREE, the first randomized clinical trial dedicated to high ...
November 07, 2016© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now